Kyeong A So
Overview
Explore the profile of Kyeong A So including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jang E, Park Y, So K, Lee S, Kim T, Shim S
Int J Gynecol Cancer
. 2025 Feb;
35(2):101615.
PMID: 39971449
No abstract available.
2.
Jang E, Lee A, So K, Lee S, Lee J, Kim T, et al.
Gynecol Oncol
. 2024 Sep;
191:19-24.
PMID: 39332276
Objective: This study aimed to assess the recurrence risk factors in patients with early-stage endometrioid endometrial cancer (EC) who achieved a complete response (CR) through fertility-sparing hormonal treatment (FST). Methods:...
3.
Bae S, Bae S, Kim H, Lim Y, Kim G, Park I, et al.
Cancer Manag Res
. 2024 Jun;
16:507-525.
PMID: 38827785
Background: Ovarian cancer is one of women's malignancies with the highest mortality among gynecological cancers. Paclitaxel is used in first-line ovarian cancer chemotherapy. Research on paclitaxel-resistant ovarian cancer holds significant...
4.
Kim W, Yang E, Jang E, Lee A, So K, Shim S, et al.
J Clin Med
. 2024 Apr;
13(8).
PMID: 38673431
: The purpose of this study was to analyze the protein overexpression and gene amplification of HER2 in endometrial carcinoma (EC) and to evaluate its role as a prognostic factor...
5.
So K, Hur S, Cho C, Lee J, Seong S, Jeong D, et al.
Sci Rep
. 2024 Mar;
14(1):7092.
PMID: 38528061
In this study, we examined the difference in the vaginal microbiota of women infected with human papillomavirus (HPV), according to menopausal status. A total of 75 cervicovaginal swab samples from...
6.
Lim Y, Kim H, Bae S, So K, Kim T, Lee J
Molecules
. 2024 Jan;
29(1).
PMID: 38202856
Paclitaxel is still used as a standard first-line treatment for ovarian cancer. Although paclitaxel is effective for many types of cancer, the emergence of chemoresistant cells represents a major challenge...
7.
Kim H, Bae S, Lim Y, So K, Kim T, Bae S, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137377
Ovarian cancer is the leading cause of death among gynecologic cancers. Paclitaxel is used as a standard first-line therapeutic agent for ovarian cancer. However, chemotherapeutic resistance and high recurrence rates...
8.
Shin D, Lee G, Kim H, So K, Hong Y, Hur M, et al.
Am J Clin Pathol
. 2023 Oct;
161(2):111-114.
PMID: 37852281
Objectives: Identification of DNT, a rare partial D, can be challenging, as it is difficult to distinguish from D+. This study aimed to identify DNT individuals by analyzing the DNT...
9.
Kim M, So K, Chun Y, Kim Y, Lim K, Lee K, et al.
Taiwan J Obstet Gynecol
. 2023 Sep;
62(5):724-728.
PMID: 37679002
Objective: To evaluate the association between mismatch repair (MMR) protein expression and clinico-pathologic outcomes in patients with endometrioid endometrial cancer (EC). Materials And Methods: A retrospective review of the clinico-pathologic...
10.
Lee A, Kim S, Jang E, Hyun J, Yang E, So K, et al.
Int J Gynaecol Obstet
. 2023 Sep;
164(2):587-595.
PMID: 37675800
Objective: To compare surgical outcomes in patients with benign diseases who underwent laparoscopically assisted vaginal hysterectomy (LAVH) to determine the association between surgical outcomes and resident participation in the gynecologic...